Alto Neuroscience, Inc. - 8-K Filing

Alto Neuroscience reported preliminary cash balance of $244.2 million as of June 30, 2026 (Items: 8.01 of this Current Report on Form 8-K is incorporated herein by reference and shall not be deemed “filed” for purposes of Section 18 of the Secu)

SEC EDGAR ·

Tickers: $ANRO

Read the full article at SEC EDGAR

More Regulatory news